The sale is part of CHS’ plan to divest a second group of hospitals with a combined revenue of $2 billion. The plan was announced earlier this year during a third quarter 2017 earnings call.
Officials expect to close the transaction during the first quarter of 2018, subject to customary closing conditions and regulatory approvals.
More articles on hospital-physician relationships:
Former Merck CEO donates $250M to Columbia University medical school to eliminate student debt
USA Today: VA knowingly hired physicians with malpractice, legal problems
California hospital removes license plate-reading camera amid controversy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
